Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisseel for Hemostasis in Vascular Surgery
NCT00576420Phase 2Completed
- Sponsor
- Baxter
- Start
- Dec 2007
- Primary completion
- Nov 2008
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tisseel (3 arms), sponsored by Baxter. Primary endpoints: Percentage of Participants Achieving Hemostasis at 4 Minutes After Treatment Application at the Study Suture Line, 90% Confidence Interval for the Percentage of Participants Achieving Hemostasis at 4 Minutes After Treatment Application at the Suture Line and 2 more. Started Dec 2007; status: completed.
02
Drugs
tisseel
Beyond the preview
Go deeper on NCT00576420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576420.